KMYY(SH:600518)2024-04-29 08:45Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,201,239,538.91, representing a year-on-year increase of 5.01%[4] - The net profit attributable to shareholders was CNY 7,471,308.45, while the net profit after deducting non-recurring gains and losses was CNY -58,476,470.08[4] - Operating profit for Q1 2024 was ¥9,589,132.70, a significant recovery from a loss of ¥50,670,611.08 in Q1 2023[17] - Total profit for Q1 2024 amounted to ¥9,664,531.98, compared to a loss of ¥44,301,446.77 in the same period last year[17] - The net profit for Q1 2024 is 8,612,816.71, a significant improvement from a net loss of -49,765,383.27 in Q1 2023[18] - The total comprehensive income for Q1 2024 is 8,591,044.15, compared to a total comprehensive loss of -49,765,917.25 in Q1 2023[18] - The net loss for Q1 2024 was $37.38 million, compared to a net loss of $45.28 million in Q1 2023, showing an improvement of 17.5%[25] Cash Flow - The net cash flow from operating activities was CNY -332,557,910.45, indicating a negative cash flow situation[4] - Cash inflow from operating activities in Q1 2024 is 1,105,246,385.75, down from 1,464,558,204.32 in Q1 2023, indicating a decrease of approximately 24.5%[19] - The total cash inflow from operating activities was significantly bolstered by other cash received related to operating activities, which amounted to 1,027,302,700.16 RMB in Q1 2024, compared to 133,940,884.15 RMB in Q1 2023[26] - The company reported a substantial increase in cash outflow related to operating activities, which reached 1,626,683,057.67 RMB in Q1 2024, compared to 110,437,675.96 RMB in Q1 2023, marking a 1370.5% increase[26] - The net cash flow from financing activities for Q1 2024 is -8,946,952.06, an improvement from -31,317,970.93 in Q1 2023[20] Assets and Liabilities - Total assets at the end of Q1 2024 were CNY 14,205,206,839.53, a decrease of 0.53% compared to the end of the previous year[6] - Non-current assets totaled ¥7,350,153,925.72, down from ¥7,470,628,620.38 in the previous quarter[15] - Total liabilities decreased to ¥7,115,934,991.92 from ¥7,199,927,544.93 in the previous quarter[15] - The company's total assets were reported at ¥14,205,206,839.53, slightly down from ¥14,280,378,964.87 in the previous quarter[15] - The company's total liabilities increased to $5.28 billion in Q1 2024, compared to $5.20 billion in Q1 2023[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 195,478, with the largest shareholder holding 25.31% of shares[10] - The top ten shareholders hold a combined total of 37.55% of the company's shares, indicating a concentrated ownership structure[10] Operational Highlights - The company is actively communicating with creditors to mitigate the impact of the bankruptcy proceedings on its operations[12] - The company will continue to monitor the bankruptcy case closely and fulfill its disclosure obligations as required by law[12] - The company’s subsidiary, Kangmei Traditional Chinese Medicine City (Puning), is undergoing bankruptcy liquidation proceedings, which may impact future operations[12] Research and Development - The company continues to invest in R&D, with expenses rising to ¥10,361,546.22 in Q1 2024 from ¥9,486,049.57 in Q1 2023[17] - Research and development expenses increased to $7.20 million in Q1 2024, up 54.5% from $4.65 million in Q1 2023[24] Inventory and Receivables - Accounts receivable increased to approximately ¥2.14 billion from ¥2.03 billion, reflecting a growth of about 5.5%[13] - Inventory rose to approximately ¥2.81 billion from ¥2.64 billion, indicating an increase of about 6.5%[13] - The total accounts receivable as of March 31, 2024, is 1,786,177,109.56, an increase from 1,680,324,390.30 as of December 31, 2023[21] - Inventory increased to $796.48 million in Q1 2024 from $699.30 million in Q1 2023, representing a rise of 13.9%[22] Other Financial Metrics - The weighted average return on net assets was 0.11%, an increase of 0.84 percentage points compared to the previous year[4] - The basic earnings per share for Q1 2024 is 0.001, recovering from a loss of -0.004 in Q1 2023[18] - The basic and diluted earnings per share for Q1 2024 were both -$0.003, consistent with Q1 2023[25]